REVIVED-BCIS2

ClinicalTrials.gov Identifier: NCT01920048

Purpose

This study will assess whether percutaneous coronary intervention (angioplasty of the heart arteries) can improve survival and reduce hospitalization in patients with heart failure due to coronary disease, who have been treated with the best contemporary medical therapy.

Condition: Ischemic Cardiomyopathy

Intervention:

Procedure: Percutaneous Coronary Intervention
Drug: Drug Therapy for Heart Failure
Device: Device Therapy for Heart Failure

Official Title:             REVascularisation for Ischaemic VEntricular Dysfunction (REVIVED): a Randomized Comparison of Percutaneous Coronary Intervention (With Optimal Medical Therapy) Versus Optimal Medical Therapy Alone for Treatment of Heart Failure Secondary to Coronary Disease

Assigned Interventions: Procedure: Percutaneous Coronary Intervention

Other Name: Coronary angioplasty/stents

Drug: Drug Therapy for Heart Failure

The optimal combination of drugs and doses for each patient will be individualized and will be determined by his/her physician, in accordance with local and international clinical practice guidelines

Device: Device Therapy for Heart Failure

The optimal device therapy for each patient will be individualized and will be determined by his/her physician, in accordance with local and international clinical practice guidelines. In most cases the device will be an Implantable Cardioverter Defibrillator and/or Cardiac Resynchronization Therapy